My Diabetes Home

What My Diabetes Home does

My Diabetes Home is a consumer-facing web and mobile platform that helps individuals with diabetes consolidate and act on their personal health data, including blood glucose readings, medications, lab results, physical activity, and appointment information. The product is built as a responsive web application accessible from any device, with integrations to glucose meters (direct upload), Fitbit activity trackers, and patient/pharmacy online portals. Differentiating technical components include the Visit Optimizer tool, which generates individualized pre-visit reports for healthcare appointments, and an Estimated A1C calculator that derives hemoglobin A1C estimates from logged glucose values without requiring a lab draw. The platform is led by a practicing endocrinologist (Dr. Anuj Bhargava) and is structured to be usable by non-technical patients while producing clinically relevant, shareable outputs.

The business model is a freemium subscription directed at individual consumers. The free tier offers core tracking features, the Visit Optimizer, an estimated A1C, the proprietary Meds Discount Card, and shareable reports. The premium tier, priced at $3.99 per month or $39.99 per year, adds glucose meter uploads, doctor and pharmacy portal data imports, prescription assistance and coupons, Fitbit activity sync, and personalized care alerts. Go-to-market is product-led: users self-register on mydiabeteshome.com, with acquisition supported by content marketing via an associated blog (iowadiabetes.com/blogs) and testimonial-driven credibility from named endocrinologists, certified diabetes educators, and past American College of Cardiology leadership. The customer base is primarily individuals with diabetes (Type 1 and Type 2), with healthcare providers (endocrinologists, CDEs, RDs) functioning as a secondary influencer segment that refers patients rather than as a direct paying channel.

The company operates as a privately held LLC (My Diabetes Home, LLC), founded in 2009 and headquartered in Des Moines, Iowa, with no disclosed institutional funding, no parent company, and no enterprise/B2B revenue channel disclosed in available materials. The team is led by Founder & CEO Dr. Anuj Bhargava (a practicing endocrinologist at Mercy Medical Center and Founder/President of Iowa Diabetes Research) and CTO Jayesh Bajaj. The "For Educators" section of the site suggests at least tentative outreach into clinician-facing use cases, though no monetization mechanism for that segment is described.

Name

My Diabetes Home

Legal name

My Diabetes Home, LLC

Website

https://mydiabeteshome.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

My Diabetes Home is a consumer-facing web and mobile platform that helps individuals with diabetes track blood glucose, medications, labs, and activity, share visit-ready reports with providers, and access a medication discount card, sold via a freemium subscription ($3.99/mo or $39.99/yr premium).

Ownership category

akta.pro rank

Product category

Diabetes Management Software

akta.pro primary industry

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)

akta.pro secondary industry

Diabetes (General) (HLAKADAA)

Keywords

• Diabetes management software
• Glucose tracking platform
• Patient health monitoring
• Medication management tools
• Chronic disease self-care

Headquarters

HQ city

Des Moines

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Freemium Subscription: Free tier provides basic sugar tracking, medication logging, estimated A1C, med discount card, and Visit Optimizer tool. Premium tier at $3.99/month or $39.99/year adds glucose meter uploads, portal data import, prescription assistance, activity integration, and personalized care alerts.
2. Subscription Recurring: Annual and monthly subscription options for premium features. Annual subscription offers cost savings ($39.99/year vs $47.88/monthly equivalent).

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

My Diabetes Home is a personalized web and mobile platform that enables individuals with diabetes to log and consolidate blood sugar readings, medications, lab results, and physical activity in a single secure location. It offers estimated A1C calculations, glucose meter uploads, integration with healthcare provider and pharmacy portals, Fitbit activity sync, and a Visit Optimizer tool that generates individualized pre-visit reports for healthcare appointments. A proprietary medication discount card and prescription assistance features help users afford their diabetes medications.

Product overview

My Diabetes Home is a single, unified consumer-facing web and mobile platform for diabetes self-management. The core product serves as a central hub where users log sugars, medications, labs, and activity. Key integrated features include the Visit Optimizer Tool for preparing individualized reports for healthcare appointments, the Meds Discount Card for prescription savings, and an Estimated A1C calculator derived from logged glucose data. The platform offers a free tier covering core tracking and a Premium tier (at $3.99/month or $39.99/year) adding glucose meter uploads, third-party portal imports, Fitbit activity sync, and personalized care alerts.

Differentiator

Problem solved

Functional benefit

Products and services

• My Diabetes Home Platform

Quantifiable outcome

• A1C reduction from 7.6 to 7.0 reported by one user through consistent tracking

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature7 records

Recent moves1 record

Expansion highlights4 records

Direct peers

• Glooko: Diabetes data unification platform that pulls data from a wide range of glucose meters, CGMs, insulin pumps, and provider portals. Direct peer on the multi-source data import and provider-facing reporting workflows that My Diabetes Home emphasizes.
• Diabetes:M: Mobile and web diabetes management application offering logbook, bolus calculator, reporting, and integrations. Comparable as a consumer-facing dashboard product competing in the same SMB/individual segment.
• One Drop: Direct-to-consumer diabetes management app combining glucose tracking, coaching, and supplies delivery. Closely comparable on the consumer freemium/SaaS play with an outcomes-driven value proposition similar to My Diabetes Home's A1C messaging.
• mySugr: Consumer diabetes self-management app acquired by Roche. Most direct competitor to My Diabetes Home with overlapping functionality in glucose logging, bolus estimation, reporting, and provider sharing, and a comparable freemium plus subscription model.

Broad incumbents

• Dexcom Clarity: CGM-maker-owned data reporting platform with deep device integration and provider-facing reports. Represents the OEM-controlled aggregator threat: incumbent leverage on the central data source (CGM) that third-party tools depend on.
• Livongo (Teladoc Health): Former standalone chronic-condition management leader (now part of Teladoc) that offered connected device, coaching, and analytics for diabetes at scale. Represents the scaled, payer-contracted version of the same outcome-based proposition My Diabetes Home targets.
• Medtronic (Diabetes): Major insulin pump and CGM manufacturer that operates its own patient and provider data platforms. Adjacent incumbent demonstrating how device OEMs are integrating services that compete with the standalone data-aggregator model.
• Verily (Onduo): Alphabet-backed chronic care platform originally focused on diabetes through Onduo; combines connected devices, virtual care, and analytics at payer/employer scale. A scaled, well-capitalized analogue that compresses the standalone aggregator opportunity.

Emerging players

• Levels Health: Metabolic health app with continuous glucose monitoring, broader than diabetes but overlapping on glucose tracking, A1C-style insights, and provider-shareable reporting; illustrates the consumer health category expansion toward diabetes-adjacent users.
• Tidepool: Diabetes data platform with strong CGM and insulin pump integrations and both consumer and clinician experiences. Comparable as a multi-device aggregator serving the same patient/provider data-unification need.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/MyDiabetesHome
• Facebookfacebook.com/mydiabeteshome
• LinkedInlinkedin.com/company/my-diabetes-home

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about My Diabetes Home